FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells

被引:179
作者
Belguise, K [1 ]
Kersual, N [1 ]
Galtier, F [1 ]
Chalbos, D [1 ]
机构
[1] INSERM, U540, F-34090 Montpellier, France
关键词
FRA-1; cell proliferation; in vitro invasion; gene expression; breast cancer cells;
D O I
10.1038/sj.onc.1208312
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Breast cancer progression is likely a multistep process involving the activation and inactivation of a number of genes. Previously, we showed that the mRNA coding for Fra-1, a FOS family member and an AP-1 transcription factor component, was highly expressed in the more invasive estrogen receptor negative (ER-) breast cancer cell lines. We used a tet-off system to stably overexpress Fra-1 in MCF7 ER + cells and evaluate the impact of Fra-1 on this aggressive phenotype. Conversely, Fra-1 was silenced in highly invasive ER-MDA-MB231 cells using RNA interference. We report that in both systems the Fra-1 expression level was positively associated with cell proliferation, cell motility and invasiveness assessed in vitro. In addition, Fra-1 inhibition in fibroblastoid ER-cells, which formed colonies with large stellate projections in Matrigel, resulted in morphological changes. Cells acquired an epithelioid shape and had a spherical appearance in Matrigel. Fra-1 regulated several genes, implicated in invasion, angiogenesis and cell proliferation independently of beta1-integrin activation, and directly induced MMP-1 and MMP-9 promoter activity. These overall results show that high Fra-1 expression is associated with a more malignant cell phenotype and suggest that Fra-1 could have a pivotal role in breast cancer progression.
引用
收藏
页码:1434 / 1444
页数:11
相关论文
共 62 条
[31]  
Li GY, 1999, CANCER RES, V59, P6267
[32]   Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine [J].
Luo, YP ;
Zhou, H ;
Mizutani, M ;
Mizutani, N ;
Reisfeld, RA ;
Xiang, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (15) :8850-8855
[33]  
MATSUI M, 1990, ONCOGENE, V5, P249
[34]   ENDOCRINE THERAPY OF BREAST-CANCER [J].
MCGUIRE, WL .
ANNUAL REVIEW OF MEDICINE, 1975, 26 :353-363
[35]   Transformation by ras modifies AP1 composition and activity [J].
Mechta, F ;
Lallemand, D ;
Pfarr, CM ;
Yaniv, M .
ONCOGENE, 1997, 14 (07) :837-847
[36]   Transcriptional regulation of cell invasion: AP-1 regulation of a multigenic invasion programme [J].
Ozanne, BW ;
McGarry, L ;
Spence, HJ ;
Johnston, I ;
Winnie, J ;
Meagher, L ;
Stapleton, G .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (13) :1640-1648
[37]   FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells [J].
Philips, A ;
Teyssier, C ;
Galtier, F ;
Rivier-Covas, C ;
Rey, JM ;
Rochefort, H ;
Chalbos, D .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (07) :973-985
[38]  
PHILIPS A, 1993, J BIOL CHEM, V268, P14103
[39]  
Price DJ, 2001, CELL GROWTH DIFFER, V12, P129
[40]  
Ramos-Nino ME, 2002, CANCER RES, V62, P6065